Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 4
2019 7
2020 1
2021 1
2022 5
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia.
Rutella S, Vadakekolathu J, Mazziotta F, Reeder S, Yau TO, Mukhopadhyay R, Dickins B, Altmann H, Kramer M, Knaus HA, Blazar BR, Radojcic V, Zeidner JF, Arruda A, Wang B, Abbas HA, Minden MD, Tasian SK, Bornhäuser M, Gojo I, Luznik L. Rutella S, et al. Among authors: mazziotta f. J Clin Invest. 2022 Nov 1;132(21):e159579. doi: 10.1172/JCI159579. J Clin Invest. 2022. PMID: 36099049 Free PMC article.
Climate Change Perception and Mental Health. Results from a Systematic Review of the Literature.
Gianfredi V, Mazziotta F, Clerici G, Astorri E, Oliani F, Cappellina M, Catalini A, Dell'Osso BM, Pregliasco FE, Castaldi S, Benatti B. Gianfredi V, et al. Among authors: mazziotta f. Eur J Investig Health Psychol Educ. 2024 Jan 12;14(1):215-229. doi: 10.3390/ejihpe14010014. Eur J Investig Health Psychol Educ. 2024. PMID: 38248134 Free PMC article. Review.
Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.
Zeidner JF, Vincent BG, Ivanova A, Moore D, McKinnon KP, Wilkinson AD, Mukhopadhyay R, Mazziotta F, Knaus HA, Foster MC, Coombs CC, Jamieson K, Van Deventer H, Webster JA, Prince GT, DeZern AE, Smith BD, Levis MJ, Montgomery ND, Luznik L, Serody JS, Gojo I. Zeidner JF, et al. Among authors: mazziotta f. Blood Cancer Discov. 2021 Sep 10;2(6):616-629. doi: 10.1158/2643-3230.BCD-21-0070. eCollection 2021 Nov. Blood Cancer Discov. 2021. PMID: 34778801 Free PMC article. Clinical Trial.
Balancing Benefits and Harms of COVID-19 Vaccines: Lessons from the Ongoing Mass Vaccination Campaign in Lombardy, Italy.
Corrao G, Rea F, Franchi M, Cereda D, Barone A, Borriello CR, Della Valle GP, Ercolanoni M, Jara J, Preziosi G, Maffeo M, Mazziotta F, Pierini E, Lecis F, Sanchirico P, Vignali F, Leoni O, Fortino I, Galli M, Pavesi G, Bertolaso G. Corrao G, et al. Among authors: mazziotta f. Vaccines (Basel). 2022 Apr 15;10(4):623. doi: 10.3390/vaccines10040623. Vaccines (Basel). 2022. PMID: 35455374 Free PMC article.
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.
Cattaneo C, Di Blasi R, Skert C, Candoni A, Martino B, Di Renzo N, Delia M, Ballanti S, Marchesi F, Mancini V, Orciuolo E, Cesaro S, Prezioso L, Fanci R, Nadali G, Chierichini A, Facchini L, Picardi M, Malagola M, Orlando V, Trecarichi EM, Tumbarello M, Aversa F, Rossi G, Pagano L; SEIFEM Group. Cattaneo C, et al. Ann Hematol. 2018 Sep;97(9):1717-1726. doi: 10.1007/s00277-018-3341-6. Epub 2018 Apr 28. Ann Hematol. 2018. PMID: 29705860
Protective action of natural and induced immunization against the occurrence of delta or alpha variants of SARS-CoV-2 infection: a test-negative case-control study.
Corrao G, Franchi M, Rea F, Cereda D, Barone A, Borriello CR, Della Valle PG, Ercolanoni M, Fortino I, Jara J, Leoni O, Mazziotta F, Pierini E, Preziosi G, Tirani M, Galli M, Bertolaso G, Pavesi G, Bortolan F. Corrao G, et al. Among authors: mazziotta f. BMC Med. 2022 Feb 8;20(1):52. doi: 10.1186/s12916-022-02262-y. BMC Med. 2022. PMID: 35130877 Free PMC article.
Mesangiogenic progenitor cells are forced toward the angiogenic fate, in multiple myeloma.
Pacini S, Montali M, Mazziotta F, Schifone CP, Macchia L, Carnicelli V, Panvini FM, Barachini S, Notarfranchi L, Previti GB, Buda G, Petrini M. Pacini S, et al. Among authors: mazziotta f. Oncotarget. 2019 Nov 26;10(63):6781-6790. doi: 10.18632/oncotarget.27285. eCollection 2019 Nov 26. Oncotarget. 2019. PMID: 31827721 Free PMC article.
21 results